Catheter Precision, Inc. (VTAK)
After hours:
| Previous Close | 0.5000 |
| Open | 0.5240 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 900 |
| Day's Range | 0.5000 - 0.5240 |
| 52 Week Range | 0.3400 - 1.3000 |
| Volume | |
| Avg. Volume | 36,573 |
| Market Cap | 3.923M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.05 |
| EPS (TTM) | 11.3000 |
| Earnings Date | Mar 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.10 |
ACCESSWIRECatheter Precision, Inc. (NYSE: VTAK) Announces Initial Orders from Ronald Reagan UCLA Medical Center and Rady Children’s Hospital in San Diego for LockeT
FORT MILL, SC / ACCESSWIRE / May 13, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company focused on electrophysiology products, announced additional product evaluations for its newest ...
- ACCESSWIRE
Catheter Precision, Inc. (VTAK) Announces Receipt of New Purchase Order and Product Evaluation at New Hospital
see attached FORT MILL, SC / ACCESSWIRE / May 7, 2024 /Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company focused on electrophysiology products, announced the receipt of a purchase order for ...
- ACCESSWIRE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report
FORT MILL, SC / ACCESSWIRE / May 6, 2024 / Catheter Precision, Inc. (NYSE American:VTAK) a MedTech company pioneering products in the growing field of cardiac electrophysiology, including its VIVO™ and LockeT product(s), releases Q1 Financials, Operational ...
